184 related articles for article (PubMed ID: 22220260)
1. Causes of adult splanchnic vein thrombosis in the mediterranean area.
De Stefano V; Za T; Ciminello A; Betti S; Rossi E
Mediterr J Hematol Infect Dis; 2011; 3(1):e2011063. PubMed ID: 22220260
[TBL] [Abstract][Full Text] [Related]
2. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment.
De Stefano V; Martinelli I
Intern Emerg Med; 2010 Dec; 5(6):487-94. PubMed ID: 20532730
[TBL] [Abstract][Full Text] [Related]
3. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
De Stefano V; Qi X; Betti S; Rossi E
Thromb Haemost; 2016 Jan; 115(2):240-9. PubMed ID: 26333846
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or non-cirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.
Fan J; Wang Q; Luo B; Chen H; Wang Z; Niu J; Yuan J; Yuan X; Bai W; He C; Guo W; Li K; Yin Z; Fan D; Han G
J Gastroenterol Hepatol; 2020 Jul; 35(7):1215-1222. PubMed ID: 31711259
[TBL] [Abstract][Full Text] [Related]
5. PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q, and Prothrombin 20210A in Splanchnic Vein Thrombosis: Analysis of Individual Patient Data From Three Prospective Studies.
Pasta L; Pasta F; D'Amico M
J Clin Exp Hepatol; 2016 Mar; 6(1):10-4. PubMed ID: 27194890
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
Karaköse S; Oruç N; Zengin M; Akarca US; Ersöz G
Turk J Gastroenterol; 2015 Jan; 26(1):42-8. PubMed ID: 25698270
[TBL] [Abstract][Full Text] [Related]
7. Management of splanchnic vein thrombosis.
Elkrief L; Payancé A; Plessier A; d'Alteroche L; Ronot M; Paradis V; Valla D; Rautou PE
JHEP Rep; 2023 Apr; 5(4):100667. PubMed ID: 36941824
[TBL] [Abstract][Full Text] [Related]
8. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.
Primignani M; Barosi G; Bergamaschi G; Gianelli U; Fabris F; Reati R; Dell'Era A; Bucciarelli P; Mannucci PM
Hepatology; 2006 Dec; 44(6):1528-34. PubMed ID: 17133457
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for thrombophilia in extrahepatic portal vein obstruction.
Primignani M; Martinelli I; Bucciarelli P; Battaglioli T; Reati R; Fabris F; Dell'era A; Pappalardo E; Mannucci PM
Hepatology; 2005 Mar; 41(3):603-8. PubMed ID: 15726653
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of extrahepatic portal vein obstruction: Myeloproliferative neoplasms eliminate hypersplenic hematologic changes in extrahepatic portal vein obstruction.
Shimizu T; Yoshida H; Taniai N; Yoshioka M; Kawano Y; Matsushita A; Ueda J; Iwai T; Murokawa T; Ono T; Hamaguchi A
Intractable Rare Dis Res; 2024 Feb; 13(1):63-68. PubMed ID: 38404733
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.
Rai P; Kumar P; Mishra S; Aggarwal R
Indian J Gastroenterol; 2016 Sep; 35(5):366-371. PubMed ID: 27633031
[TBL] [Abstract][Full Text] [Related]
12. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
13. Thrombophilia Profile in Budd-Chiari Syndrome and Splanchnic Vein Thrombosis: A Study from Western India.
Sawant P; Vashishtha C; Nasa M; Parikh P; Patel J; Agasti A
J Assoc Physicians India; 2015 Sep; 63(9):32-5. PubMed ID: 27608864
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
De Stefano V; Teofili L; Leone G; Michiels JJ
Semin Thromb Hemost; 1997; 23(5):411-8. PubMed ID: 9387199
[TBL] [Abstract][Full Text] [Related]
15. Splanchnic vein closures.
Krška Z; Kvasnička J; Hořejš J; Hoskovec D
Rozhl Chir; 2019; 98(6):239-244. PubMed ID: 31331179
[TBL] [Abstract][Full Text] [Related]
16. Budd-Chiari Syndrome in a Patient with JAK-2 V617F and Factor V G1691A Mutations.
Velarde-Félix JS; Sanchez-Zazueta J; Gonzalez-Ibarra FP; González-Valdez JA; Salcido-Gómez B; Gallardo-Angulo E; Murillo-Llanes J
West Indian Med J; 2014 Sep; 63(5):528-31. PubMed ID: 25781296
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
Yonal I; Pinarbası B; Hindilerden F; Hancer VS; Nalcaci M; Kaymakoglu S; Diz-Kucukkaya R
J Thromb Thrombolysis; 2012 Oct; 34(3):388-96. PubMed ID: 22569900
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.
How J; Zhou A; Oh ST
Ther Adv Hematol; 2017 Mar; 8(3):107-118. PubMed ID: 28246554
[TBL] [Abstract][Full Text] [Related]
19. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.
Janssen HL; Meinardi JR; Vleggaar FP; van Uum SH; Haagsma EB; van Der Meer FJ; van Hattum J; Chamuleau RA; Adang RP; Vandenbroucke JP; van Hoek B; Rosendaal FR
Blood; 2000 Oct; 96(7):2364-8. PubMed ID: 11001884
[TBL] [Abstract][Full Text] [Related]
20. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.
Smalberg JH; Arends LR; Valla DC; Kiladjian JJ; Janssen HL; Leebeek FW
Blood; 2012 Dec; 120(25):4921-8. PubMed ID: 23043069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
